The Floodlight MS app, used to track disease progression in people with multiple sclerosis, has been deemed cost-effective in ...

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

The following is a summary of “Real-world satisfaction and experience with injection and autoinjector device for ofatumumab ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.